Spotlight
Clinical Role
Clinical
Supplement Spotlight
CE
Subscribe
Video
How Can Access to Costly Specialty Drugs be Improved?
Author(s):
Kevin James, RPh, MBA, vice president of payer strategy at US Bioservices, discusses challenges for patients in accessing specialty medications.
Kevin James, RPh, MBA, vice president of payer strategy at US Bioservices, discusses challenges for patients in accessing specialty medications.
Related Videos
Related Content
